Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Airlines are expected to make nearly $10 billion in profits this year, despite a slowing economy, according to a new forecast from the International Air Transport Association.
U.S. stocks are drifting Monday to begin what could be a quiet stretch following weeks of gains that rallied Wall Street to the edge of what's called a “bull market."
